Astrana Health, Inc. (ASTH)

37.61USD -1.31% (-0.50)

Over 3Y: +0.1%

2026-08-25
20 40 60
2023 2024 2025 2026

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 57 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.1
OE margin 1.4%
ROIC 5.8%

Valuation

What does the price ask for what the company earns, owns and pays out?

5.5
EV/EBIT 26.2×
EV/OE 49.1×

Durability

How predictable is the revenue, and how much of it is already committed?

5.3
RPO / sales 0.00069×

Resilience

Can the balance sheet absorb a bad year?

2.4
ND/EBITDA -0.2

Growth

Is the business getting bigger, and is it getting more profitable?

5.4
Sales/sh Y/Y +54.4%
Sales CAGR 4Y +42.4%

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.

Revenue by fiscal year

As the company reported it, one row per year, straight from the filings.

Fiscal yearEndsRevenue
20182018-12-31 519,908,000
20192019-12-31 560,618,000
20202020-12-31 687,180,000
20212021-12-31 773,915,000
20222022-12-31 1,144,163,000
20232023-12-31 1,386,661,000
20242024-12-31 2,034,540,000
20252025-12-31 3,181,769,000

The ratios

The figures themselves rather than their scores — what somebody looking up ASTH on one particular measure came for.

RatioValue
cash operating margin5.31
current ratio1.23
current ratio reported1.23
deferred revenue growth65.57
dilution pct2.91
ebit cagr-1.06
ebit yoy43.37
ev ebit26.19
ev owner earnings49.07
ev sales0.68
fcf margin2.46
growth cv0.46
interest cover1.49
net debt ebitda3.27
operating margin2.61
owner earnings margin1.39
revenue growth58.91
revenue growth per share54.41
roic5.82
rule of 4061.52
sbc pct revenue1.06

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 13,494,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 402,013,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 919,160,000 AssetsCurrent 2026-06-30
current liabilities 747,639,000 LiabilitiesCurrent 2026-06-30
equity 830,224,000 StockholdersEquity 2026-06-30
interest expense 67,336,000 InterestExpenseNonoperating 2026-06-30
ocf 107,873,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 3,844,194,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 40,764,000 ShareBasedCompensation 2026-06-30

What to be careful about

See it scored yourself

The dashboard puts ASTH beside other companies and lets you change what counts: the weight of each dimension, the value that earns a ten, and which of the 61 measures are included at all.